Jane Chandler

Part of Medica Group Plc, JCA Seminars Ltd. is a medical training company based in Hastings, UK. The British company offers worldwide radiology and medical CPD training in various specialist fields such as gynae, breast, cardiac CT, MRI, and paediatrics. The company welcomes sponsors from different backgrounds and specialities such as Phantoms, Ultrasound Equipment, and Recruitment agencies. JCA Seminars emphasizes the importance of bowel cancer screening in detecting bowel cancer at an early stage. The company was founded in 2003 by Jane Elizabeth Chandler, who has been the CEO since then. JCA Seminars was acquired by Medica Group Plc on March 29, 2023 for $1.73 million.

Part of Medica Group Plc, JCA Seminars Ltd. is a medical training company based in Hastings, UK. The British company offers worldwide radiology and medical CPD training in various specialist fields such as gynae, breast, cardiac CT, MRI, and paediatrics. The company welcomes sponsors from different backgrounds and specialities such as Phantoms, Ultrasound Equipment, and Recruitment agencies. JCA Seminars emphasizes the importance of bowel cancer screening in detecting bowel cancer at an early stage. The company was founded in 2003 by Jane Elizabeth Chandler, who has been the CEO since then. JCA Seminars was acquired by Medica Group Plc on March 29, 2023 for $1.73 million.

Part of Medica Group Plc, JCA Seminars Ltd. is a medical training company based in Hastings, UK. The British company offers worldwide radiology and medical CPD training in various specialist fields such as gynae, breast, cardiac CT, MRI, and paediatrics. The company welcomes sponsors from different backgrounds and specialities such as Phantoms, Ultrasound Equipment, and Recruitment agencies. JCA Seminars emphasizes the importance of bowel cancer screening in detecting bowel cancer at an early stage. The company was founded in 2003 by Jane Elizabeth Chandler, who has been the CEO since then. JCA Seminars was acquired by Medica Group Plc on March 29, 2023 for $1.73 million.